Patents Assigned to Addiction Research Foundation
  • Patent number: 5145864
    Abstract: A method is provided for treating warm-blooded animals so as to reduce their voluntary alcohol consumption comprising the administration to the animals of an angiotensin converting enzyme inhibitor.
    Type: Grant
    Filed: September 15, 1987
    Date of Patent: September 8, 1992
    Assignee: Alcoholism and Drug Addiction Research Foundation
    Inventors: Larry A. Grupp, Edward Perlanski, Robert B. Stewart
  • Patent number: 5110813
    Abstract: A method of use of an angiotensin converting enzyme inhibitor is provided which comprises administration of the inhibitor to warm-blooded animals so as to reduce their voluntary alcohol consumption. The method further includes combining the use of opiate receptor antagonist to further reduce alcohol consumption.
    Type: Grant
    Filed: September 29, 1989
    Date of Patent: May 5, 1992
    Assignee: Alcoholism and Drug Addiction Research Foundation
    Inventors: Larry A. Grupp, Edward Perlanski, Robert B. Stewart
  • Patent number: 4628866
    Abstract: The present invention relates to a simultaneous matched feeding apparatus. The apparatus includes two tube-like members containing liquids. The upper portions of the tubes are interconnected to allow air pressure in the upper portions of the tubes to equilibrate such that when one liquid is removed from one of the tubes, the other tube automatically dispenses a corresponding amount of another liquid.
    Type: Grant
    Filed: June 21, 1984
    Date of Patent: December 16, 1986
    Assignee: Alcoholism & Drug Addiction Research Foundation
    Inventors: Yedy Israel, Betsavel Oporto, Alain Macdonald
  • Patent number: 4396606
    Abstract: Novel opioid compounds are provided having a phenolic hydroxyl and a pentet of alternating basic hydrophilic and hydrophobic groups derived from basic amino acids and hydrophobic amino acids. Desirably, the pentet, usually sextet, is separated from the phenolic ring by at least about 3 atoms in a chain, preferably at least about 15 atoms in a chain and not more than about 30 atoms in a chain (for rings one will take the average of the shortest and longest distances). Particularly, a polypeptide is provided having tyrosyl at the amine end, desirably as the first amino acid of leu- or met-enkephalin and a sextet of alternating basic hydrophilic and hydrophobic amino acids spaced from the enkephalin by at least about one amino acid. Desirably, the polypeptide is at least 1,200 molecular weight and under about 2,500 molecular weight.
    Type: Grant
    Filed: November 5, 1979
    Date of Patent: August 2, 1983
    Assignee: Addiction Research Foundation
    Inventor: Avram Goldstein
  • Patent number: 4306291
    Abstract: Apparatus is provided in which a signal indicative of the tremor is sensed. This signal is amplified in a variable gain amplifier. During an initial time interval the size of the amplifier signal is determined and the gain of the amplifier is adjusted in response to the signal size. Then means are provided for indicating the size of frequency of the adjusted signal during a further time period to give a tremor measurement which may be relatively easily interpreted.
    Type: Grant
    Filed: December 14, 1979
    Date of Patent: December 15, 1981
    Assignee: Alcoholism & Drug Addiction Research Foundation
    Inventors: Duane H. Zilm, Howard L. Kaplan, Dominique M. Durand